MedApp SA
0.18
PLN
+0.00
(+0.28%)
ISIN
PLYLWHT00012
Return %
Stock
S&P 500
1Y
15.48
14.20
3Y
-55.14
81.12
5Y
-81.28
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- David Odrakiewicz
- Full Time Employees
- 40
- Sector
- Technology services
- Industry
- Packaged software
- Address
- Kraków Poland
- IPO Date
- Oct 19, 2011
- Website
- medapp.pl
- Similar Companies
- Business
- MedApp S.A. is a medical technology software company that develops artificial intelligence-driven digital medicine, 3D holographic visualization, and advanced telemedicine solutions. Founded in 2009 and headquartered in Krakow, Poland, the company operates within the healthcare technology and software as a medical device (SaMD) sector, serving hospitals, surgical clinics, interventional cardiology centers, oncology departments, and outpatient healthcare providers across Europe, North America, and the Middle East. The company develops and commercializes specialized clinical software solutions, including CarnaLife Holo, a mixed-reality diagnostic imaging platform that transforms computed tomography (CT), magnetic resonance imaging (MRI), and echocardiography scan data into interactive three-dimensional holograms rendered on Microsoft HoloLens 2 headsets for pre-operative planning and intra-operative guidance; CarnaLife Holo MedNav, an advanced augmented reality surgical navigation software that provides real-time tracking of surgical instruments inside anatomical holograms without requiring external optical navigation hardware; CarnaLife System, a cloud-based telemedicine and diagnostic analytics platform that integrates with more than 20 medical monitoring devices, including electrocardiographs, pulse oximeters, blood pressure monitors, and spirometers, to perform continuous remote patient monitoring, clinical triage, and automated AI data interpretation; Digital Clinic (Cyfrowa Przychodnia), an integrated teleconsultation, patient record management, and remote diagnostic triage portal; and HoloComm, a mixed-reality collaboration and interactive visualization platform used for remote clinical consultations, medical device demonstrations, and surgical training. The company holds international regulatory clearances, including Class II 510(k) clearance from the United States Food and Drug Administration (FDA) and European Union CE Mark certification under the Medical Device Regulation (MDR) for its core holographic visualization technologies. In recent operational and strategic developments, MedApp S.A. serves as a flagship SME in the European Union-funded 7.8 million euro VR Health Champions consortium under the Interregional Innovation Investments (I3) instrument to advance the clinical deployment and sensor integration of CarnaLife Holo MedNav in collaboration with partners including Lightspace; entered into strategic co-development and regulatory alignment agreements with SDS Optic and Accrea Medical Robotics to integrate mixed-reality navigation into robotic biopsy systems; advanced commercial distribution channels and FDA clearance preparations for its surgical navigation platform in the United States; carried out corporate restructuring proceedings; and executed leadership and governance changes with David Odrakiewicz serving as President of the Management Board and the Doktor Guzik Family Foundation becoming the controlling shareholder.